Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rapoport

Showing results (91-100 of 179) with videos related to

Pageof 18
Sort By:
Leukemia|April 30, 2022
Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansionMichael L Olson, Erica R Vander Mause, Sabarinath V Radhakrishnan, et al.
American Journal of Hematology|May 20, 1998
Treatment of multifocal lymphoma of bone with intensified ProMACE-CytaBOM chemotherapy and involved field radiotherapyA P Rapoport, L S Constine, C H Packman, et al.
Leukemia Research|January 18, 2003
Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposideJavier Bolaños-Meade, Judith E Karp, Chuanfa Guo, et al.
American Journal of Hematology|April 2, 2020
Severe dysautonomia as a manifestation of neurotoxicity after CAR-T cell therapy for diffuse large B-cell lymphomaFiras El Chaer, Ariel Siegel, Noa G Holtzman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 3, 2020
Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantationGabriela Sanchez-Petitto, Noa G Holtzman, Ali Bukhari, et al.
Leukemia & Lymphoma|July 9, 2019
Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myelomaVu H Duong, Noa G Holtzman, Rima Koka, et al.
Bone Marrow Transplantation|October 28, 2003
Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cellsA P Rapoport, B L Levine, A Badros, et al.
Blood|May 3, 2017
Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myelomaAshraf Badros, Elizabeth Hyjek, Ning Ma, et al.
Blood Advances|December 19, 2022
Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myelomaTaiga Nishihori, James E Hoffman, Anne Huff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcomeA P Rapoport, J M Rowe, P A Kouides, et al.
Pageof 18

Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
Leukemia|April 30, 2022
Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansionMichael L Olson, Erica R Vander Mause, Sabarinath V Radhakrishnan, et al.
American Journal of Hematology|May 20, 1998
Treatment of multifocal lymphoma of bone with intensified ProMACE-CytaBOM chemotherapy and involved field radiotherapyA P Rapoport, L S Constine, C H Packman, et al.
Leukemia Research|January 18, 2003
Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposideJavier Bolaños-Meade, Judith E Karp, Chuanfa Guo, et al.
American Journal of Hematology|April 2, 2020
Severe dysautonomia as a manifestation of neurotoxicity after CAR-T cell therapy for diffuse large B-cell lymphomaFiras El Chaer, Ariel Siegel, Noa G Holtzman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 3, 2020
Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantationGabriela Sanchez-Petitto, Noa G Holtzman, Ali Bukhari, et al.
Leukemia & Lymphoma|July 9, 2019
Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myelomaVu H Duong, Noa G Holtzman, Rima Koka, et al.
Bone Marrow Transplantation|October 28, 2003
Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cellsA P Rapoport, B L Levine, A Badros, et al.
Blood|May 3, 2017
Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myelomaAshraf Badros, Elizabeth Hyjek, Ning Ma, et al.
Blood Advances|December 19, 2022
Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myelomaTaiga Nishihori, James E Hoffman, Anne Huff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcomeA P Rapoport, J M Rowe, P A Kouides, et al.
Pageof 18